1. Preclinical Development of CAR T Cells with Antigen-Inducible IL18 Enforcement to Treat GD2-Positive Solid Cancers;Fischer-Riepe;Clin. Cancer Res.,2024
2. Detection of ganglioside GD2 in tumor tissues and sera of neuroblastoma patients;Schulz;Cancer Res.,1984
3. Expression of GD2 and GD3 gangliosides in human embryonic neural stem cells;Yanagisawa;ASN Neuro,2011
4. Anti-GD2 antibody with GM-CSF, interleukin-2, and isotretinoin for neuroblastoma;Yu;N. Engl. J. Med.,2010
5. Interleukin 2 with anti-GD2 antibody ch14.18/CHO (dinutuximab beta) in patients with high-risk neuroblastoma (HR-NBL1/SIOPEN): a multicentre, randomised, phase 3 trial;Ladenstein;Lancet Oncol.,2018